Computational study on the drug resistance mechanism of HCV NS3 protease to BMS-605339

Biotechnology and Applied Biochemistry
Huiqun WangMingjuan Ji

Abstract

NS3 protease plays a vital role in the replication of the hepatitis C virus (HCV). BMS-605339 is a novel linear tetra-peptide α-ketoamide inhibitor of NS3 protease and shows specificity for HCV NS3 protease genotype 1a and genotype 1b. Mutation at the key site 168 of the HCV NS3 protease can induce resistance to BMS-605339, which greatly affects the antiviral therapy efficacy to hepatitis C. In the present study, we employed molecular dynamics simulations, free energy calculations, and free energy decomposition to explore the drug resistance mechanism of BMS-605339 due to the three representative mutations D168C/Y/V. The free energy decomposition analysis indicates that the decrease in the binding affinity is mainly attributed to the decrease in both van der Waals and electrostatic interactions. After detailed analysis of our calculated results, we observed that the break of the salt bridge between residues 155 and 168 caused by the mutations D168C/Y/V is the original reason for the decrease in the binding ability between BMS-605339 and the mutant NS3 proteases. The obtained results will reveal the drug resistance mechanism between BMS-605339 and the mutant NS3 proteases, and provide valuable clue for designing novel and more p...Continue Reading

References

Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·W Wang, P A Kollman
Sep 5, 2002·Journal of Computational Chemistry·Ray LuoMichael K Gilson
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 3, 2002·Gastroenterology·John G McHutchisonUNKNOWN International Hepatitis Interventional Therapy Group
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·UNKNOWN National Institutes of Health
Dec 4, 2003·Journal of Computational Chemistry·Holger Gohlke, David A Case
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Doris B StraderUNKNOWN American Association for the Study of Liver Diseases
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Oct 4, 2005·Journal of Computational Chemistry·David A CaseRobert J Woods
Feb 7, 2006·Journal of Molecular Graphics & Modelling·Junmei WangDavid A Case
May 16, 2006·Progress in Medicinal Chemistry·Peter W WhiteMichael Bös
Jan 28, 2009·Antimicrobial Agents and Chemotherapy·Tse-I LinKenneth Simmen
Dec 7, 2011·Antimicrobial Agents and Chemotherapy·Guanghui YiC Cheng Kao
Jan 19, 2012·Antimicrobial Agents and Chemotherapy·Christoph WelschIris Antes
Mar 7, 2012·Pharmacotherapy·Olga M KlibanovShannon H Williams
Oct 19, 2012·The Journal of Physical Chemistry. B·Kin Wai LeiX-Y Zhu
Dec 12, 2012·Journal of Computer-aided Molecular Design·Lingling GengBozhen Chen
Jan 30, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Michal UsarekJadwiga Bryla
Apr 5, 2014·Journal of Pharmaceutical Sciences·Susan JenkinsKenneth Santone

❮ Previous
Next ❯

Citations

Jun 5, 2021·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Miłosz ParczewskiJerzy Jaroszewicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.